D-Wave, Quantums

D-Wave Quantum's Second Government Infusion Hits a Wall of Profit-Taking

26.05.2026 - 19:02:59 | boerse-global.de

D-Wave Quantum shares slip 3.87% after 58% surge, as overbought RSI triggers profit-taking. Government grants up to $100M and record bookings buoy long-term outlook.

D-Wave Quantum's Second Government Infusion Hits a Wall of Profit-Taking - Bild: über boerse-global.de
D-Wave Quantum's Second Government Infusion Hits a Wall of Profit-Taking - Bild: über boerse-global.de

The euphoria surrounding D-Wave Quantum's back-to-back government grants gave way to a sobering Tuesday session, as the stock retreated from its recent highs. After surging more than 58% over the previous seven trading days, the shares slipped 3.87% to €24.82, having touched an intraday low of €23.27 that represented a nearly 10% drop from the prior close. The relative strength index, at 70.1, confirmed what chartists had been warning: the rally had pushed the stock into overbought territory, and profit-taking was inevitable.

The catalyst for the earlier climb was a double dose of state funding. On May 26, D-Wave's subsidiary Quantum Circuits LLC secured the second financing phase for its SQFab project, a program focused on "Improved Materials for Superconducting Qubits with Scalable Fabrication." The grant, awarded by NORDTECH – a regional semiconductor research consortium based in New York – is part of a broader allocation of more than $25 million across four selected projects that had successfully completed their first-year milestones. D-Wave did not disclose its specific share, but the technical targets are clear: advanced materials for superconducting qubits, scalable manufacturing processes, and the demonstration of quantum error correction using new circuits and control schemes. This is a move from research toward actual production.

Just five days earlier, the company had signed a non-binding memorandum for a much larger award under the CHIPS and Science Act: up to $100 million in government funding, to be exchanged for equity in D-Wave. That deal is part of a $2.013 billion government initiative supporting nine quantum firms, including two foundries and seven developers. TD Cowen ranked D-Wave among the three biggest beneficiaries, alongside Rigetti Computing and GlobalFoundries. While the CHIPS agreement covers broader technology development and includes a government ownership stake, the SQFab grant is narrower, drilling down into materials, packaging, and testing for superconducting quantum systems.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

The flurry of government support dovetails with a surge in commercial demand. In its most recent quarter, D-Wave posted record bookings of $33.4 million, a 1,994% jump year-over-year, while remaining performance obligations climbed 563% to $42.4 million. Revenue, however, fell to $2.9 million from the prior-year period, which had included a system sale. The net loss widened to $18.4 million. D-Wave's cash position of $588.4 million provides ample runway for its dual-track strategy: advancing its core quantum-annealing business while building out gate-model systems.

Management will lay out the gate-model roadmap on June 1 at its investor day at the New York Stock Exchange, followed by the Qubits Europe conference in London on June 18. Both events will test whether the recent government endorsements can translate into sustained investor confidence. For now, the stock is digesting a 66% rally over just three sessions, and the technical overhang suggests that the next leg higher may require a period of consolidation.

Ad

D-Wave Quantum Stock: New Analysis - 26 May

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

en | US26740W1099 | D-WAVE | boerse | 69421967 |